Kingfa Sci. & Tech. stock
600143.SSSHHKingfa Sci. & Tech. Co., Ltd., Basic MaterialsISIN CNE000001JP3
44Score 44 out of 100, Weak
Price and trend
41 / 100
Price history
−32% in one yearThe chart shows daily closes over 20 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 23% below it.
Since April 2026 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 39).
The price is 43% below its 52-week high. Largest decline in 20 years: 87% (August 2007 to November 2008).
Chart figures for advanced users
- SMA 50$1.94
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$2.39
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)39
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.79
- The lowest closing price of the last twelve months.
- Resistance$3.22
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- Kingfa Sci. & Tech. Co., Ltd. belongs to the Chemicals (Specialty) industry (China) and, with a market value of $4.91B, is number 64 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $9.79B (up 7.9% year on year) and earnings of $172.38M (up 39.4%).
- MEQIRI Score 44 out of 100 (Weak): rank 365 of 467 in Basic Materials, median 58.
Show more
- The P/E is 34.8 (Chemicals (Specialty) median 20.2, own median of recent years 23.9).
- Our model puts fair value at $3.02, with the price 37% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings turn into cashFree cash flow above 500% of earnings over the last 12 months.Fundamentals 64
- Analysts expect strong earnings growthUp 38.2% a year through 2028 (estimates from 3 analysts).
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 64
Weaknesses
- Earnings per share fallingDown 24% a year since 2020.Growth 48
- Richly valuedP/E 34.8, Chemicals (Specialty) median 20.2, own median 23.9.Valuation 69
- Share price fell sharplyDown 40% over the last 12 months.Momentum 21
The score is held back by profitability and momentum.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 43 to 44.
The fundamentals are in the middle range.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk not measured
How well MEQIRI warnsFor stocks from Japan, China, Hong Kong, Taiwan, Korea, Canada, India and Brazil we only show crash risk once a separate backtest shows that it warns as well there as in the US and Europe.
Valuation
Valuation signal
Possible value trapClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $2.16 and expensive above $5.03 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $4.97 (cash-flow model) and $1.07 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 8.9%. At 9.9% the fair value would be $2.67, at 7.9% it would be $3.49.
Possible value trap: looks cheap, but score below 50.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (20.2).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue fell 0.9% on the twelve months before. Revenue has grown strongly since 2006, at around 15% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 12%, operating 4%, net 2%.
Debt & balance sheet
latest quarterDebt is elevated. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 27 Apr 2027in 166 days
- Last reported
- 26 Oct 2026EPS reported $0.01 (expected $0.03)below expectations
Analyst estimates
Earnings estimates have barely changed since 25 Oct 2026.
- Earnings per share
- $0.090.0%
- Revenue
- $10.82B0.0%
- Earnings per share
- $0.130.0%
- Revenue
- $11.87B0.0%
MEQIRI has stored the estimates since 25 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
What happened at Kingfa Sci. & Tech.
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 44
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Xinjiang Daqo New Energy688303.SS $5.47B32
- LB Group002601.SZ $5.45B46
- Sumitomo Chemical4005.T $5.32B53
- Navin Fluorine InternationalNAVINFLUOR.NS $5.29B79
- Sensient TechnologiesSXT $5.06B59
- Perimeter SolutionsPRM $5.02B56
- ArkemaAKE.PA $5B50
- Dottikon ES HoldingDESN.SW $4.81B61
ETFs that hold Kingfa Sci. & Tech.
Held by 27 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers Harvest CSI A500 UCITS ETF 1DAH50 | 0.11% | 0.65% | €10.8M |
| Amundi MSCI China A UCITS ETF AccCNAA | 0.08% | 0.35% | €83.52M |
| Amundi MSCI China ESG Selection Extra UCITS ETF AccLCHI | 0.02% | 0.65% | €473.19M |
Show 5 more
| HSBC MSCI China UCITS ETFH4ZP | 0.02% | 0.28% | €865.21M |
| Franklin FTSE China UCITS ETFFLXC | 0.01% | 0.19% | €1.3B |
| UBS MSCI China Universal UCITS ETF USD disUETC | 0.01% | 0.30% | €134.65M |
| Amundi MSCI Emerging Markets ESG Selection UCITS ETF DR (C)SADM | 0.01% | 0.18% | €1.02B |
| Vanguard FTSE Emerging Markets UCITS ETF (USD) AccumulatingVFEA | 0.00% | 0.17% | €5.24B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = CN¥6.6707)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 6 Mar 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.